Comparison of dynamic contrast‐enhanced MR , ultrasound and optical imaging modalities to evaluate the antiangiogenic effect of PF ‐03084014 and sunitinib-Reference-Cited by-同舟云学术

Comparison of dynamic contrast‐enhanced MR , ultrasound and optical imaging modalities to evaluate the antiangiogenic effect of PF ‐03084014 and sunitinib

Published:2014-02-27 Issue:3 Volume:3 Page:462-471
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Zhang Cathy C.¹,Yan Zhengming¹,Giddabasappa Anand²,Lappin Patrick B.³,Painter Cory L.¹,Zhang Qin¹,Li Gang¹,Goodman James⁴,Simmons Brett¹,Pascual Bernadette¹,Lee Joseph¹,Levkoff Ted²,Nichols Tim⁴,Xie Zhiyong⁴

Affiliation:

1. Oncology Research Unit Pfizer Global Research and Development La Jolla California

2. Comparative Medicine Pfizer Global Research and Development La Jolla California

3. Drug Safety Pfizer Global Research and Development La Jolla California

4. Precision Medicine Pfizer Global Research and Development Groton Connecticut

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.215

Reference35 articles.